Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:00:32 UTC |
---|
Update Date | 2020-02-26 21:39:16 UTC |
---|
HMDB ID | HMDB0013943 |
---|
Secondary Accession Numbers | - HMDB0060572
- HMDB13943
- HMDB60572
|
---|
Metabolite Identification |
---|
Common Name | Alpha-hydroxyalprazolam |
---|
Description | Alpha-hydroxyalprazolam is a metabolite of both alprazolam and adinazolam. Alprazolam (trade name Xanax, available among other generic names) is a short-acting anxiolytic of the benzodiazepine class of psychoactive drugs. Alprazolam, like other benzodiazepines, binds to specific sites on the GABAA gamma-amino-butyric acid receptor. Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. (Wikipedia) Alpha-hydroxyalprazolam belongs to the family of Benzodiazepines. These are organic compounds containing a benzene ring fused to either isomers of diazepine(unsaturated seven-member heterocycle with two nitrogen atoms replacing two carbon atoms). |
---|
Structure | OCC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12 InChI=1S/C17H13ClN4O/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)19-9-15-20-21-16(10-23)22(14)15/h1-8,23H,9-10H2 |
---|
Synonyms | Value | Source |
---|
a-Hydroxyalprazolam | Generator | Α-hydroxyalprazolam | Generator | alpha-Hydroxyalprazolam | MeSH |
|
---|
Chemical Formula | C17H13ClN4O |
---|
Average Molecular Weight | 324.764 |
---|
Monoisotopic Molecular Weight | 324.077788765 |
---|
IUPAC Name | {12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methanol |
---|
Traditional Name | {12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methanol |
---|
CAS Registry Number | 37115-43-8 |
---|
SMILES | OCC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12 |
---|
InChI Identifier | InChI=1S/C17H13ClN4O/c18-12-6-7-14-13(8-12)17(11-4-2-1-3-5-11)19-9-15-20-21-16(10-23)22(14)15/h1-8,23H,9-10H2 |
---|
InChI Key | ZURUZYHEEMDQBU-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,2,4-triazolo[4,3-a][1,4]benzodiazepines. These are aromatic compounds containing a 1,4-benzodiazepine fused to and sharing a nitrogen atom with a 1,2,4-triazole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,2,4-triazolo[4,3-a][1,4]benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,2,4-triazolo[4,3-a][1,4]benzodiazepine
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Azole
- Heteroaromatic compound
- 1,2,4-triazole
- Ketimine
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Alcohol
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Aromatic alcohol
- Imine
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxyalprazolam GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4j-3091000000-e7762ed5dd501c19ee15 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxyalprazolam GC-MS (1 TMS) - 70eV, Positive | splash10-00di-9424000000-81b35a2bc2115fbf4987 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxyalprazolam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Alpha-hydroxyalprazolam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 10V, Positive-QTOF | splash10-004i-0009000000-79798e77b8d69605062f | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 20V, Positive-QTOF | splash10-004i-0029000000-b4787b48477d0e4688b5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 40V, Positive-QTOF | splash10-0udi-3190000000-08211acca653b8eb7ec2 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 10V, Negative-QTOF | splash10-00di-0049000000-17f3ea1c0dac5eeee2c5 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 20V, Negative-QTOF | splash10-0059-0091000000-db7d3fc90c0cbc67e511 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 40V, Negative-QTOF | splash10-0udi-2290000000-65f784f4f83baaa57e11 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 10V, Negative-QTOF | splash10-00di-0039000000-13f6188a0b76667d548a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 20V, Negative-QTOF | splash10-00di-2039000000-f03b146ba7b5102df5b9 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 40V, Negative-QTOF | splash10-0ue9-4091000000-2624d76bab723ccf09bf | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 10V, Positive-QTOF | splash10-004i-0009000000-17da94791e2d780448e0 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 20V, Positive-QTOF | splash10-004i-0009000000-e6e523193fcf5f3c90e0 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Alpha-hydroxyalprazolam 40V, Positive-QTOF | splash10-066r-3290000000-8b26b4a66f1dbad024ae | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|